PHARMACEUTICAL COMPOSITION FOR CO-ADMINISTRATION OF ANTICANCER AGENTS USING EXOSOME SECRETION CONTROL TECHNOLOGY PASSING THROUGH CALCIUM SIGNALS

摘要

The present invention relates to a method for increasing a co-administration effect of anticancer agents by controlling secretion capacity of exosomes by utilizing calcium signal transduction mechanism regulation technology inside and outside of cells. A pharmaceutical composition for co-administration for preventing or treating cancer containing anticancer agents and an exosome secretion regulator according to the present invention can occur a synergistic effect by co-administration and can maximize an anticancer effect while minimizing side effects by minimizing a dosage of an existing anticancer agent.;COPYRIGHT KIPO 2019